SEC Form 4 · accession 0001437749-18-008666
BIOLARGO, INC. · BLGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jack B. Strommen
Director
Period of report
May 2, 2018
Accepted (ET)
May 4, 2018 · 2:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000880242
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 2, 2018 | C | 1,450,400 | $0.25 | A | 2,106,298 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Convertible Promissory NoteF2,F3 | $0.25 | May 2, 2018 | C | — | D | Sep 9, 2015 | Jun 1, 2018 | Common Stock | 1,000,000 | — | D |
| Convertible Promissory NoteF2,F3 | $0.25 | May 2, 2018 | C | — | D | Aug 26, 2015 | Jun 1, 2018 | Common Stock | 400,000 | — | D |
Explanation of responses
- F1Shares were issued to Reporting Person in exchange for conversion of promissory notes issued in exchange for $350,000 of investments in Issuer's 2015 Unit Offering, and include shares issued as payment of both principal and accrued interest oustanding.
- F2Represents the conversion price set forth in the Convertible Promissory Note reported herein.
- F3Includes two investments into Issuer's "unit" securities offerings in the aggregate amount.